These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19098509)

  • 1. Quitting smoking without a psychotic break: the potential link between nicotinic acetylcholine receptor partial agonists and neuropsychiatric adverse events.
    O'Malley P
    Clin Nurse Spec; 2009; 23(1):13-5. PubMed ID: 19098509
    [No Abstract]   [Full Text] [Related]  

  • 2. Smoking cessation: an overview of treatment options with a focus on varenicline.
    Stack NM
    Pharmacotherapy; 2007 Nov; 27(11):1550-7. PubMed ID: 17963463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.
    Coe JW; Brooks PR; Vetelino MG; Wirtz MC; Arnold EP; Huang J; Sands SB; Davis TI; Lebel LA; Fox CB; Shrikhande A; Heym JH; Schaeffer E; Rollema H; Lu Y; Mansbach RS; Chambers LK; Rovetti CC; Schulz DW; Tingley FD; O'Neill BT
    J Med Chem; 2005 May; 48(10):3474-7. PubMed ID: 15887955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Varenicline: the French experience after 6 months.
    Prescrire Int; 2009 Feb; 18(99):25. PubMed ID: 19396936
    [No Abstract]   [Full Text] [Related]  

  • 5. Varenicline (Chantix) warnings: risk versus benefit.
    Med Lett Drugs Ther; 2008 Jul; 50(1290):53. PubMed ID: 18617873
    [No Abstract]   [Full Text] [Related]  

  • 6. Exacerbation of recurrent depression as a result of treatment with varenicline.
    Popkin MK
    Am J Psychiatry; 2008 Jun; 165(6):774. PubMed ID: 18519539
    [No Abstract]   [Full Text] [Related]  

  • 7. [New drugs; varenicline].
    van Bronswijk H; Dubois EA; Zitman FG; Cohen AF
    Ned Tijdschr Geneeskd; 2007 Nov; 151(45):2503-4. PubMed ID: 18062594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute coronary syndrome: an uncommon serious complication of smoking cessation with varenicline].
    Sanz Sanz CL; Meyer García-Sipido E; Fuentes Ponte M; Del Nogal Sáez F
    Med Clin (Barc); 2014 Feb; 142(4):179-80. PubMed ID: 23706682
    [No Abstract]   [Full Text] [Related]  

  • 9. Empowering dental hygienists: tobacco cessation resources.
    Perno Goldie M
    Int J Dent Hyg; 2008 May; 6(2):148-9. PubMed ID: 18412729
    [No Abstract]   [Full Text] [Related]  

  • 10. Varenicline and the evaluation of neuropsychiatric adverse events in smokers.
    O'Malley SS
    Biol Psychiatry; 2011 Jun; 69(11):1017-8. PubMed ID: 21550436
    [No Abstract]   [Full Text] [Related]  

  • 11. Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation.
    Rollema H; Coe JW; Chambers LK; Hurst RS; Stahl SM; Williams KE
    Trends Pharmacol Sci; 2007 Jul; 28(7):316-25. PubMed ID: 17573127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varenicline (Chantix) for tobacco dependence.
    Med Lett Drugs Ther; 2006 Aug 14-28; 48(1241-1242):66-8. PubMed ID: 16977281
    [No Abstract]   [Full Text] [Related]  

  • 13. Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers.
    Faessel HM; Smith BJ; Gibbs MA; Gobey JS; Clark DJ; Burstein AH
    J Clin Pharmacol; 2006 Sep; 46(9):991-8. PubMed ID: 16920893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varenicline and pheochromocytoma.
    Hukkanen J; Ukkola O; Benowitz NL
    Ann Intern Med; 2010 Mar; 152(5):335-6. PubMed ID: 20194248
    [No Abstract]   [Full Text] [Related]  

  • 15. Thoughts and acts of aggression/violence toward others reported in association with varenicline.
    Moore TJ; Glenmullen J; Furberg CD
    Ann Pharmacother; 2010 Sep; 44(9):1389-94. PubMed ID: 20647416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varenicline for tobacco dependence.
    Tavares AR
    N Engl J Med; 2009 Feb; 360(7):731. PubMed ID: 19222131
    [No Abstract]   [Full Text] [Related]  

  • 17. [New smoking cessation preparations unsuitable in mental disorders].
    Lakartidningen; 2007 Jun 4-11; 104(23):1825. PubMed ID: 17655031
    [No Abstract]   [Full Text] [Related]  

  • 18. The risk of adverse cardiovascular events from varenicline balanced against the benefits in mortality from smoking cessation.
    Kistler CE; Goldstein AO
    Nicotine Tob Res; 2012 Dec; 14(12):1391-3. PubMed ID: 22422928
    [No Abstract]   [Full Text] [Related]  

  • 19. A manic episode in a 64-year-old man: an adverse effect of varenicline.
    Ahmed AI
    Gen Hosp Psychiatry; 2011; 33(2):200.e9-200.e11. PubMed ID: 21596218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varenicline (champix)-associated manic relapse in bipolar affective disorder.
    MacSuibhne S; Giwa TA; McCauley MD
    Ir Med J; 2010 Oct; 103(9):286. PubMed ID: 21186758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.